Compositions for the Treatment of Metastatic Cancer
CA2965671A1
Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
WO2015195071A1
Pharmaceutical compounds
CN105142643A
Pharmaceutical compounds
WO2011102906A1
Imageable lipid-oil-water nanoemulsion delivery system
WO2011102905A1
Imageable lipid-oil-water nanoemulsion diagnostic delivery system
WO2011102904A1
Imageable lipid-oil-water nanoemulsion therapeutic delivery system
WO2011046583A1
Pharmaceutical exploitation of oxidative stress in transformed cells
WO2011005310A1
Pharmaceutical composition
WO2010110887A1
Fatty acids
WO2010062381A1
Organelle-specific drug delivery
WO2010019225A1
Pharmaceutical composition
WO2009123595A1
Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
BRPI0821894A2
Pharmaceutically acceptable phosphorylation state modulator of at least one enzyme and / or enzyme complex, or subunits thereof, in mitochondria of diseased cells of warm-blooded animals, including humans, method of modulating at least one enzyme or enzyme complex , or a subunit thereof, in a patient having a disease, condition, or syndrome including a change in the phosphorylation state of at least one enzyme and / or an enzyme complex, or a subunit thereof, and method to diagnose and predict benefit in a patient who has symptoms of a disease, condition, or syndrome that includes a change in the phosphorylation state of at least one enzyme and / or enzyme complex, or a subunit thereof
KR20110004846A
Modulation of enzymatic structure, activity, and/or expression level
